Tech Innovator Achieves Breakthrough Multi-Market Success
Source: Streetwise Reports  (1/15/25)
Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock. More >

Should You Double Down on This Story Stock?
Source: Chris Temple  (1/7/25)
Chris Temple of The National Investor explains why he believes you might want to double down on BioLargo Inc. (BLGO:OTCQX). More >

AI Company Unlocks Breakthrough Medical Diagnostics Platform
Source: Streetwise Reports  (1/6/25)
One company being listed on Cboe Canada starting January 8 is using AI and smartphones to help patients get quick and accurate diagnosis of their sore throats, helping to battle microbial resistance that threatens the effectiveness of antibiotics worldwide. More >

Medical Equipment Co. Shows Strong Profit Margin
Source: Dr. Douglas Loe  (12/20/24)
Despite this, the Buy-rated company remains undervalued by the markets due to ongoing business risk, noted a Leede Financial Inc. report. More >

Intratubal Insemination Device Shown Effective, Safe
Source: Emily Bodnar  (12/3/24)
Pregnancy rates with this "only new innovation for infertility in decades" were "impressive" in a pivotal study in women with male factor infertility, noted an H.C. Wainwright & Co. report. More >

Developer of Medical Instruments Attracts Research Coverage
Source: Douglas Loe  (12/2/24)
Both of this Buy-rated company's two business divisions are contributing to topline growth, noted a Leede Financial Inc. report. More >

Two Firms Aim To Create Functional Cure for Type 1 Diabetes
Source: Streetwise Reports  (11/22/24)
Each company is pursuing its own treatment approach to achieve insulin independence, consisting of islet cells (donor or stem cell derived), delivered into the portal vein or housed in a Cell Pouch bio-hybrid organ that is implanted in the body. Learn more about their respective programs. More >

Opportunity Arises for Co. With Cell Pouch
Source: Dr. Douglas Loe  (11/12/24)
This medical device owner could team up with a biotech firm that just prioritized its diabetes program, noted a Leede Financial Inc. report. More >

Revolutionary AI Tools Take Center Stage in Medical Education Symposium
Source: Streetwise Reports  (11/5/24)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has announced the release of its newly updated Medical Education Suite (MES). Read more to find out how this update is set to transform medical education and enhance training efficiency.

More >

Medical Co. Ready for a Transformative F2025
Source: Dr. Douglas Loe  (11/5/24)
The Leede Financial Inc. analyst also noted that while F2024 is a transition year for Profound Medical Corp. (PROF:NASDAQ; PRN:TSX), F2025 is expected to be transformative for U.S. TULSA-PRO adoption. rates. More >

Regenerative Medicine Co. May Have Solution to Delivering Cell Treatments
Source: Streetwise Reports  (10/28/24)
This Canadian life sciences firm is developing an implantable cell-containing pouch, shown in clinical trial data thus far to be safe, well-tolerated and effective. Learn why several analysts rate the company Buy. More >

Revolutionizing Chronic Disease Treatment Through Regenerative Medicine
Source: Streetwise Reports  (9/17/24)
A regenerative medicine therapeutics company focused on developing technologies to address chronic diseases through a regenerative approach, Sernova Corp. (SVA:TSX.V; SEOVF:OTCMKTS; XETRA:PSH) is focused on reforming healthcare through technology. See why experts and analysts are praising this company's potential. More >

Co's. Cell Pouch Performs Well in Study
Source: Dr. Douglas Loe  (9/16/24)
Data show the device keeps the incorporated therapeutic cells alive and functioning for at least five years, noted a Leede Financial Inc. report. More >

Implanted Cell Device Reaches 5 Year Milestone
Source: Stefan Quenneville  (9/16/24)
This pouch, loaded with pancreatic islet cells, is being evaluated in patients with insulin-dependent Type 1 diabetes, noted a Ventum Capital Markets report. More >

Trial Data Help Position Cell Pouch for Commercial Success
Source: Dr. Joseph Pantginis  (9/16/24)
The upside implied in the target price on this Canadian firm, developing regenerative medicine platform technologies, is 1,900%, noted an H.C. Wainwright & Co. report. More >

Is It Now Time To Buy This Biotech Stock?
Source: Clive Maund  (9/16/24)
Technical Analyst Clive Maund shares his thoughts on Sernova Corp. (SVA:TSX.V; SEOVF:OTCMKTS; XETRA:PSH) to explain why he believes it is a good stock to accumulate, between the current price and recent lows. More >

Biotech Co. Says New Data Show Success of Type 1 Diabetes Treatment
Source: Streetwise Reports  (9/12/24)
Clinical stage biotechnology company Sernova Corp. (SVA:TSX.V; SEOVF:OTCMKTS; XETRA:PSH) has released new data that show success in using its Cell Pouch Transplant System to help Type 1 diabetes patients reach insulin independence. One author says the company is David taking on Goliath in the race for a cure. More >

Co. Expands Telehealth Contract to New State
Source: Streetwise Reports  (5/22/24)
Reliq Health Technologies Inc. announced that a large U.S. health group has expanded its contract with the telehealth company to cover facilities in a new state. Read why one analyst thinks the stock is a Buy. More >

Healthcare Co. Welcomes Possible AI Funding Effort in Canada
Source: Streetwise Reports  (4/9/24)
Canadian artificial intelligence (AI) and machine learning healthcare company Treatment.com AI Inc. is using AI to positively disrupt the healthcare sector. Canada is planning to fund the industry in a big way. More >

Biotech Stocks Break Out
Source: Ron Struthers  (3/19/24)
Ron Struthers of Struthers Stock Report shares that the S&P Biotech SPDR is over 60% this year and trading around $100 a share. He also details how well he has down, buying under valued cash-rich biotechs in 2023, and shares one stock he believes it worth looking into. More >

Bionic Medical Co. Has Sufficient Funds to Operate Through 2024
Source: Dr. Swayampakula Ramakanth  (3/5/24)
Ekso Bionics Holdings Inc.'s fourth quarter of 2023 financial results were in line with estimates, according to H.C. Wainwright & Co. More >

Telehealth Co. Adding Thousands to Large Contract
Source: Streetwise Reports  (1/10/24)
Reliq Health Technologies Inc. has signed a contract expansion with a large U.S. health plan, possibly adding as many as 50,000 new patients to its iUGO telehealth platform. More >

Cryoablation System Gets Approved in Brazil
Source: Dr. Yi Chen  (9/7/23)
The product developer expects to generate US$6.6 million in sales of this medical device in Brazil over the next five years, noted an H.C. Wainwright & Co. report. More >

Med Tech Firm's Q2/23 Revenue Beats Target
Source: Scott Henry  (8/10/23)
The company is expected to gain greater market share in one segment of its business, warranting a price target increase, noted a ROTH Capital Partners report. More >

Telehealth Co. Continues To See Soaring Revenues
Source: Streetwise Reports  (8/2/23)
This telemedicine company just had its first profitable quarter, and now it could see revenues double twice over two fiscal years. More >